BioMérieux’s Acute Kidney Injury Assay Cleared in Europe

BioMérieux’s NephroCheck test has gained a CE mark for detecting kidney stress and identifying patients at risk of acute kidney injury.

The test can determine the presence of two urinary biomarkers produced by stressed kidney cells. The biomarkers serve as early warning signs of acute kidney injury in hospitalized and critically ill patients.

The assay, which provides results in 20 minutes, is used alongside a clinical evaluation in intensive care unit patients aged 21 and older to determine their risk of moderate or severe acute kidney injury.